Results 61 to 70 of about 1,076,152 (158)

Primary Immunodeficiency Diseases: A Patient-Oriented Problem-Solving (POPS) Exercise

open access: yesMedEdPORTAL, 2010
Introduction This exercise on primary immunodeficiency diseases is designed as a small-group discussion module to be used for first- or second-year medical students.
Kelly Jackson   +2 more
doaj   +1 more source

Establishment and Development of the First Biobank of Inflammatory Bowel Disease, Suspected to Primary Immunodeficiency Diseases in Iran

open access: yesAdvanced Biomedical Research, 2018
Background: Inflammatory bowel disease (IBD) might be an immunodeficiency rather than an excessive inflammatory reaction. IBD, suspected to primary immunodeficiency diseases biobank (IBDSPIDB) as a resource for researches can help improve the prevention,
Roya Sherkat   +11 more
doaj   +1 more source

BT595, a 10% Human Normal Immunoglobulin, for Replacement Therapy of Primary Immunodeficiency Disease: Results of a Subcohort Analysis in Children [PDF]

open access: hybrid, 2022
Gergely Kriván   +12 more
openalex   +1 more source

Editorial: The role of transcription factors in inborn errors of immunity

open access: yesFrontiers in Immunology, 2023
Delfien J. Bogaert   +5 more
doaj   +1 more source

P142 Inflammatory bowel diseases associated with primary immunodeficiency: a multicenter study [PDF]

open access: bronze, 2022
Georgia Malamut   +14 more
openalex   +1 more source

Transition practice for primary immunodeficiency diseases in Southeast Asia: a regional survey. [PDF]

open access: yesFront Immunol, 2023
Chan CM   +19 more
europepmc   +1 more source

From idiopathic infectious diseases to novel primary immunodeficiencies [PDF]

open access: bronze, 2005
Jean‐Laurent Casanova   +6 more
openalex   +1 more source

Primary Immunodeficiency Disease Mimicking Pediatric Bechet’s Disease [PDF]

open access: gold, 2021
Mayuka Shiraki   +4 more
openalex   +1 more source

Efficacy, Safety, and Pharmacokinetics of a Novel Human Immune Globulin Subcutaneous, 20 % in Patients with Primary Immunodeficiency Diseases in North America

open access: yesJournal of Clinical Immunology, 2016
Patients with primary immunodeficiency disease (PIDD) typically require life-long intravenous (IV) or subcutaneous (SC) immunoglobulin (Ig) replacement therapy to prevent recurrent infections.
D. Suez   +12 more
semanticscholar   +1 more source

Advances of gene therapy for primary immunodeficiencies [version 1; referees: 2 approved]

open access: yesF1000Research, 2016
In the recent past, the gene therapy field has witnessed a remarkable series of successes, many of which have involved primary immunodeficiency diseases, such as X-linked severe combined immunodeficiency, adenosine deaminase deficiency, chronic ...
Fabio Candotti
doaj   +1 more source

Home - About - Disclaimer - Privacy